title: Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients.
authors.forename: F
authors.initials: F
authors.lastname: Canta
authors.forename: R
authors.initials: R
authors.lastname: Marrone
authors.forename: S
authors.initials: S
authors.lastname: Bonora
authors.forename: A
authors.initials: A
authors.lastname: D'Avolio
authors.forename: M
authors.initials: M
authors.lastname: Sciandra
authors.forename: A
authors.initials: A
authors.lastname: Sinicco
authors.forename: F G
authors.initials: FG
authors.lastname: De Rosa
authors.forename: G
authors.initials: G
authors.lastname: Di Perri
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D016174:Hepacivirus / Q000187:drug effects* / Q000378:metabolism; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D061466:Lopinavir; D008297:Male; D008875:Middle Aged; D011744:Pyrimidinones / Q000493:pharmacokinetics / Q000633:toxicity*; D019438:Ritonavir / Q000493:pharmacokinetics / Q000633:toxicity*
chemical_list: D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir